Samer Chmait News Today : Breaking News, Live Updates & Top Stories | Vimarsana

San Diego-based Neomorph, a company focused on novel drug development for hard-to-treat diseases, has raised $109 million in a Series A round.  The round was led by Deerfield Management Co., who also participated in the company's seed round. Founded in 2020, the company recently opened a research facility in Sorrento Mesa. Neomorph’s founders are responsible for several fundamental scientific developments in the “molecular glue” field. Molecular glues are types of molecules that encourage proteins to come together that normally would not interact. "We believe there continues to be a si...

Neomorph, Inc., a San Diego, CA-based biotechnology company, raised $109m in Series A financing. The company intends to use the funds to further develop its platform, advance lead programs, and expand the research team. Deerfield Management Company established Neomorph earlier this year with scientific founders Phil Chamberlain, DPhil; Eric Fischer, PhD; Benjamin Ebert, MD, PhD; and Scott Armstrong, MD, PhD. The company is building a protein degradation entity, focused on “molecular glue” degraders. Targeted protein degradation offers opportunities to develop novel therapeutics across a...